Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2008-8-12
pubmed:abstractText
Producing an alternative to human erythrocytes has been one the most exciting dreams of medicine. Hemoglobin-based oxygen carriers (HBOCs) derived from purified human or bovine hemoglobin have been studied for clinical use and one product is currently available in the United States and European Union for veterinary use, and another in South Africa for human use.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1744-7682
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1425-33
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
pubmed:affiliation
David Geffen School of Medicine at UCLA, UCLA Department of Anesthesiology, CHS 56-122, Box 951778, Los Angeles, CA 90095-1778, USA. JSJahr@mednet.ucla.edu
pubmed:publicationType
Journal Article, Review